169 related articles for article (PubMed ID: 9565627)
1. Abnormal properties of prion protein with insertional mutations in different cell types.
Priola SA; Chesebro B
J Biol Chem; 1998 May; 273(19):11980-5. PubMed ID: 9565627
[TBL] [Abstract][Full Text] [Related]
2. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.
Moore RA; Herzog C; Errett J; Kocisko DA; Arnold KM; Hayes SF; Priola SA
Protein Sci; 2006 Mar; 15(3):609-19. PubMed ID: 16452616
[TBL] [Abstract][Full Text] [Related]
3. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
Priola SA; Chabry J; Chan K
J Virol; 2001 May; 75(10):4673-80. PubMed ID: 11312338
[TBL] [Abstract][Full Text] [Related]
4. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
Priola SA; Chesebro B
J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
[TBL] [Abstract][Full Text] [Related]
5. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
Lawson VA; Priola SA; Wehrly K; Chesebro B
J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
7. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
Vorberg I; Chan K; Priola SA
J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
[TBL] [Abstract][Full Text] [Related]
8. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
Baron GS; Caughey B
J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
[TBL] [Abstract][Full Text] [Related]
9. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes.
Baron GS; Wehrly K; Dorward DW; Chesebro B; Caughey B
EMBO J; 2002 Mar; 21(5):1031-40. PubMed ID: 11867531
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation influences cross-species formation of protease-resistant prion protein.
Priola SA; Lawson VA
EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
[TBL] [Abstract][Full Text] [Related]
11. Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform.
Vorberg I; Groschup MH; Pfaff E; Priola SA
J Virol; 2003 Feb; 77(3):2003-9. PubMed ID: 12525634
[TBL] [Abstract][Full Text] [Related]
12. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
[TBL] [Abstract][Full Text] [Related]
13. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
Horiuchi M; Caughey B
EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of transmissible spongiform encephalopathies.
Weber T; Aguzzi A
Intervirology; 1997; 40(2-3):198-212. PubMed ID: 9450236
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor-induced differentiation does not alter the biochemical properties of a mutant prion protein expressed in PC12 cells.
Chiesa R; Harris DA
J Neurochem; 2000 Jul; 75(1):72-80. PubMed ID: 10854249
[TBL] [Abstract][Full Text] [Related]
16. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro.
Lawson VA; Priola SA; Meade-White K; Lawson M; Chesebro B
J Biol Chem; 2004 Apr; 279(14):13689-95. PubMed ID: 14736880
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.
Caughey WS; Raymond LD; Horiuchi M; Caughey B
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12117-22. PubMed ID: 9770449
[TBL] [Abstract][Full Text] [Related]
18. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
Horiuchi M; Priola SA; Chabry J; Caughey B
Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
20. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
